Cargando…
Evervac: phase I/II study of immunogenicity and safety of a new adjuvant-free TBE vaccine cultivated in Vero cell culture
Approximately 10,000 cases of tick-borne encephalitis (TBE), a serious disease of the central nervous system caused by tick-borne encephalitis virus (TBEV), are registered worldwide every year. Vaccination against TBE remains the most essential measure of preventing the disease. Unlike available TBE...
Autores principales: | Vorovitch, Mikhail F., Grishina, Karina G., Volok, Viktor P., Chernokhaeva, Liubov L., Grishin, Konstantin V., Karganova, Galina G., Ishmukhametov, Aidar A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553679/ https://www.ncbi.nlm.nih.gov/pubmed/32429733 http://dx.doi.org/10.1080/21645515.2020.1757990 |
Ejemplares similares
-
Comparison of the Immunogenicity and Safety of Two Pediatric TBE Vaccines Based on the Far Eastern and European Virus Subtypes
por: Vorovitch, Mikhail F., et al.
Publicado: (2019) -
Experimental Evaluation of the Protective Efficacy of Tick-Borne Encephalitis (TBE) Vaccines Based on European and Far-Eastern TBEV Strains in Mice and in Vitro
por: Chernokhaeva, Liubov L., et al.
Publicado: (2018) -
Experimental Assessment of Possible Factors Associated with Tick-Borne Encephalitis Vaccine Failure
por: Tuchynskaya, Ksenia, et al.
Publicado: (2021) -
Genetic description of a tick-borne encephalitis virus strain Sofjin with the longest history as a vaccine strain
por: Vorovitch, M. F., et al.
Publicado: (2015) -
Exploring of Primate Models of Tick-Borne Flaviviruses Infection for Evaluation of Vaccines and Drugs Efficacy
por: Pripuzova, Natalia S., et al.
Publicado: (2013)